These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Dose response effects of avian influenza (H7N7) vaccination of chickens: serology, clinical protection and reduction of virus excretion. Maas R; Tacken M; van Zoelen D; Oei H Vaccine; 2009 Jun; 27(27):3592-7. PubMed ID: 19464539 [TBL] [Abstract][Full Text] [Related]
23. The unmet need in the elderly: designing new influenza vaccines for older adults. McElhaney JE Vaccine; 2005 Jul; 23 Suppl 1():S10-25. PubMed ID: 15908062 [TBL] [Abstract][Full Text] [Related]
24. [Seasonal variations in the reactivity to live influenza vaccines]. ZHDANOV VM; RITOVA VV Vestn Akad Med Nauk SSSR; 1962; 17(2)():3-9. PubMed ID: 14010217 [No Abstract] [Full Text] [Related]
25. Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children. Nolan T; Richmond PC; Formica NT; Höschler K; Skeljo MV; Stoney T; McVernon J; Hartel G; Sawlwin DC; Bennet J; Ryan D; Basser RL; Zambon MC Vaccine; 2008 Nov; 26(50):6383-91. PubMed ID: 18801398 [TBL] [Abstract][Full Text] [Related]
26. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination. Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415 [TBL] [Abstract][Full Text] [Related]
27. ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients. Lindemann M; Witzke O; Lütkes P; Fiedler M; Kreuzfelder E; Philipp T; Roggendorf M; Grosse-Wilde H Clin Immunol; 2006 Sep; 120(3):342-8. PubMed ID: 16631409 [TBL] [Abstract][Full Text] [Related]
31. Observations on the character of an epidemic of influenza and on the effects of vaccination. HAAPANEN E; NORO L Arh Hig Rada; 1953; 4(4):521-8. PubMed ID: 13149426 [No Abstract] [Full Text] [Related]
32. [Influenza vaccination. A choice for oneself]. Panchaud C Krankenpfl Soins Infirm; 2003; 96(10):22-4, 47-9, 62-4. PubMed ID: 14618871 [No Abstract] [Full Text] [Related]
33. Influenza: a case for an improved link between vaccine research and public health. Palache AM Immunol Lett; 2009 Feb; 122(2):137. PubMed ID: 19100772 [No Abstract] [Full Text] [Related]
34. [New influenza. What you should know about vaccination (interview by Dr. Judith Neumaier)]. Haas W MMW Fortschr Med; 2009 Aug; 151(34-35):12. PubMed ID: 19771780 [No Abstract] [Full Text] [Related]
35. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination. Muhamed G; Greenbaum E; Zakay-Rones Z Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048 [TBL] [Abstract][Full Text] [Related]
36. Pre- or post-pandemic influenza vaccine? Osterhaus AD Vaccine; 2007 Jun; 25(27):4983-4. PubMed ID: 17555851 [No Abstract] [Full Text] [Related]
37. [Influenza vaccination? An extra vaccine for seniors?]. MMW Fortschr Med; 2003 Sep; 145(37):61. PubMed ID: 14584449 [No Abstract] [Full Text] [Related]
38. NEW technologies for meeting the global demand for pandemic influenza vaccines. Fedson DS Biologicals; 2008 Nov; 36(6):346-9. PubMed ID: 18715803 [TBL] [Abstract][Full Text] [Related]
40. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer. Jo YM; Song JY; Hwang IS; Lee J; Oh SC; Kim JS; Kim SR; Kim WJ; Cheong HJ J Med Virol; 2009 Apr; 81(4):722-7. PubMed ID: 19235853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]